GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (TSE:4543) » Definitions » Quality Rank

Terumo (TSE:4543) Quality Rank


View and export this data going back to 1982. Start your Free Trial

What is Terumo Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:
  • Interest coverage
  • Zscore
  • Debt to revenue
  • Equity to asset
  • Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:
  • Operating margin mean rank (10-year mean average profit margine)
  • Operating margin growth rank
  • Fscore
  • Predictability rank
  • Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
  • Num of year profit (number of years that is profitable within the last 10 years)
  • ROIC median (10-year median of ROIC)

Terumo Quality Rank Related Terms

Thank you for viewing the detailed overview of Terumo's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Terumo (TSE:4543) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Terumo Corp (TSE:4543) » Definitions » Quality Rank
Comparable Companies
TSE:7733 TSE:6869 TSE:7747 TSE:7741 TSE:3360 TSE:7730 TSE:7716 TSE:8086 TSE:7780 TSE:7817 ISRG XPAR:EL BDX XSWX:ALC WST XSWX:STMN OCSE:COLO B RMD XPAR:DIM BAX
Traded in Other Exchanges
TRUMY:USA TRUMF:USA TUO:Germany
Address
2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Website
https://www.terumo.com
Terumo Corp manufactures and sells medical products and equipment. The firm has three main businesses: blood management, cardiac and vascular, and general hospital. The cardiac and vascular business generates the largest proportion of revenue and sells cardiac and endovascular interventional therapies, cardiovascular surgical systems, neurovascular products, and vascular graft products. The general hospital business includes diabetes management, consumer healthcare, drug and device technologies, and general hospital products. The blood management business sells blood component, therapeutic apheresis, and cellular technologies. Terumo generates the majority of its revenue in Asia, with Japan contributing the largest proportion of Asian revenue.